Table 3. Comparison of biochemical parameters between anemic vs non-anemic patients.
| No anemia (n = 18) | Anemia (n = 21) | p-value | |||
|---|---|---|---|---|---|
| Clinical characteristics | Age, years | Median (IQR, range) | 56 (16, 38–73) | 60 (12, 27–82) | 0.144 |
| Gender | Male Female |
12 (66.7%) 6 (33.3%) |
15 (71.4%) 6 (28.6%) |
0.748 | |
| Chemotherapy within 6 months |
Yes No |
11 (61.1%) 7 (38.9%) |
15 (71.4%) 6 (28.6%) |
0.496 | |
| Metastasis* | Yes No |
14 (87.5%) 2 (12.5%) |
17 (89.5%) 2 (10.5%) |
1.000 | |
| MCV, fL | 92.06 ± 0.81 | 92.27 ± 2.29 | 0.932 | ||
| Biochemical parameters | Ferritin, ng/mL | Median (IQR) | 166.7 ± 29.7 | 295.0 ± 55.5 | 0.050 |
| sTfR, ug/mL | Mean ± SD | 0.69 (0.49) | 1.28 (0.77) | 0.009 | |
| CRP, mg/L | Median (IQR) | 1.55 (5.89) | 4.95 (33.19) | 0.055 | |
| Hepcidin, ng/mL | Median (IQR) | 7.05 (8.91) | 12.99 (22.61) | 0.324 | |
Abbreviates: SD, standard deviation; IQR, interquartile range
*
Lymphoma patients (n = 4) were excluded from the analysis